Dr. Timothy D. Moore

About Timothy D. Moore

Education:

• Earned a Medical degree (MD) from the University of Pittsburgh School of Medicine.
• Completed an Internship at the University of Cincinnati School of Medicine.
• Served as Chief Resident during his Residency at Mercy Hospital in Pittsburgh.
• Undertook a Fellowship in Hematology/Oncology at The Ohio State University School of Medicine.

Experience:

• Held Senior Investigator positions at the National Cancer Institute, focusing on the Cancer Therapy Evaluation Program.
• Served as an Attending physician at NCI-Navy Medical Oncology Services, Bethesda National Naval Hospital.
• Co-Medical Director for Palliative Care at The Zangmeister Cancer Center.
• Board certified in General Internal Medicine, Hematology, Medical Oncology, and Hospice & Palliative Care Medicine.

Area of expertise

Affiliated Hospitals

The Mark H Zangmeister Center

Genesis Healthcare System Cancer Care Center

Clinical Trials Timothy D. Moore is currently running

Lomustine + Standard Therapy

for Glioblastoma

This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.

Recruiting2 awards Phase 34 criteria

Symptom Monitoring

for Young Women on Hormone Therapy

This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.

Recruiting1 award N/A13 criteria

More about Timothy D. Moore

Other Doctors you might be interested in

Frequently asked questions